| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.670 | 12.040 | 8.483 | 9.815 | 1.308 | 20.730 | 42.419 | 36.895 | 49.555 |
| Total Income - EUR | - | 1.670 | 12.041 | 8.483 | 9.815 | 1.308 | 20.730 | 42.421 | 36.897 | 49.559 |
| Total Expenses - EUR | - | 230 | 262 | 115 | 150 | 226 | 5 | 683 | 18.632 | 14.605 |
| Gross Profit/Loss - EUR | - | 1.441 | 11.779 | 8.369 | 9.665 | 1.082 | 20.724 | 41.738 | 18.265 | 34.954 |
| Net Profit/Loss - EUR | - | 1.390 | 11.418 | 8.114 | 9.370 | 1.047 | 20.115 | 40.676 | 17.967 | 33.497 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Epidemiologic Consult Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 849 | 1.885 |
| Current Assets | - | 1.708 | 11.559 | 14.598 | 18.485 | 13.753 | 28.367 | 41.013 | 27.288 | 36.833 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 557 | 985 | 1.074 | 0 | 7 | 3.032 | 35.157 | 14.281 | 27.944 |
| Cash | - | 1.151 | 10.574 | 13.524 | 18.485 | 13.747 | 25.335 | 5.857 | 13.007 | 8.889 |
| Shareholders Funds | - | 1.435 | 11.470 | 14.505 | 18.431 | 13.753 | 28.013 | 40.724 | 26.955 | 33.545 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 273 | 89 | 93 | 54 | 0 | 355 | 289 | 1.182 | 5.173 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epidemiologic Consult Med Srl